Biotechnology institutions necessarily work through representations: regulatory categories, financing models, product definitions, milestones, market forecasts, and measurements. These tools make coordinated action possible. They become dangerous when success within the representation begins to stand in for success in the underlying physical system.
Carbocene is designed around the opposite ordering. Biological efficacy and physical outcomes remain primary. Financing, regulation, commercialization, philanthropy, licensing, and partnerships are different mechanisms for carrying useful biology forward.
Carbocene builds on years of plant-biotechnology research initiated at Living Carbon, including engineered aspen and conifer programs. When Living Carbon discontinued development and commercialization of its synthetic-biology tree program, Carbocene was established in its present nonprofit form as an independent pathway for continued research and new development.
By that transition, the work already extended from industrial propagation and repeated lead-event validation to replicated field experiments, advanced loblolly pine (Pinus taeda) event selection, and functioning eastern cottonwood (Populus deltoides) transformation. The institutional pathway changed; the biological questions remained.
Carbocene’s intellectual origins precede Living Carbon. Patrick Mellor began developing the framework at the 2019 Foresight Planeteers workshop around biological productivity, carbon flux, decomposition, durable materials, and the integration of engineered plants into larger physical systems. He subsequently developed the work with Linda Maepa and Rob Ferber. Living Carbon became one important setting in which parts of this program were developed. Carbocene now pursues the broader program independently.
Regulatory categories, financing models, product definitions, and organizational milestones matter because they shape how useful biology reaches the world. They should not substitute for the question of whether the biology itself works.
Commercial products, licensing, industrial partnerships, grants, philanthropy, and productive land use can each support continued development.
Independence and provenance: Carbocene is independent of Living Carbon. It holds a nonexclusive license covering the specifically identified Deer photosynthesis-enhanced hybrid aspen line for noncommercial research and related nonprofit use within the United States, subject to its terms. Living Carbon is not currently involved, and the license does not imply endorsement, ownership by Carbocene of Living Carbon technology, or unrestricted commercial rights. Carbocene’s Photosynthetic Systems Engineering and ePRB work is separate and independently developed.